Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8+ T cells derived from autoantigen-deficient mice

Frontiers in Immunology

Volumn 2, Issue MAY, 2011, Pages

  Leech, Melanie D ^a   Carrillo Vico, Antonio ^a,e   Liblau, Roland S ^b,c,d   Anderton, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSERM   (France)

^c CNRS   (France)

^d Université Paul Sabatier   (France)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Eae; Multiple sclerosis

Indexed keywords

EID: 81755180291     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00017     Document Type: Article

References (50)

1. Anderson, A. C., Nicholson, L. B., Legge, K. L., Turchin, V., Zaghouani, H., and Kuchroo, V. K. (2000). High frequency of autoreactive myelin pro-teolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191, 761-770.
2. Anderton, S. M., Manickasingham, S. P., Burkhart, C., Luckcuck, T. A., Holland, S.J., Lamont, A. G., and Wraith, D. C. (1998). Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity. J. Immunol. 161, 3357-3364.
3. Anderton, S. M., and Wraith, D. C. (2002). Selection and fine-tuning of the autoimmune T-cell repertoire. Nat. Rev. Immunol. 2, 487-498.
4. Babbe, H., Roers, A., Waisman, A., Lass-mann, H., Goebels, N., Hohlfeld, R., Friese, M., Schroder, R., Deckert, M., Schmidt, S., Ravid, R., and Rajew-sky, K. (2000). Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipula-tion and single cell polymerase chain reaction.J. Exp. Med. 192, 393-404.
5. Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., and Kuchroo, V. K. (2003). Myelin oligo-dendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081.
6. Bettini, M., Rosenthal, K., and Evavold, B. D. (2009). Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE. J. Neuroimmunol. 213, 60-68.
7. Carrillo-Vico, A., Leech, M. D., and Anderton, S. M. (2010). Contribution of myelin autoantigen citrulli-nation to T cell autoaggression in the central nervous system. J. Immunol. 184, 2839-2846.
8. Coles, A. J., Cox, A., Le Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., and Compston, D. A. (2006). The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J. Neurol. 253, 98-108.
9. Delarasse, C., Daubas, P., Mars, L. T., Vizler, C., Litzenburger, T., Iglesias, A., Bauer, J., Della Gaspera, B., Schubart, A., Decker, L., Dimitri, D., Roussel, G., Dierich, A., Amor, S., Dautigny, A., Liblau, R., and Pham-Dinh, D. (2003). Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest. 112, 544-553.
10. Fazilleau, N., Delarasse, C., Sweenie, C. H., Anderton, S. M., Filla-treau, S., Lemonnier, F. A., Pham-Dinh, D., and Kanellopoulos, J. M. (2006). Persistence of autoreactive myelin oligodendrocyte glycopro-tein (MOG)-specific T cell repertoires in MOG-expressing mice. Eur. J. Immunol. 36, 533-543.
11. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., and Anderton, S. M. (2002). B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950.
12. Flugel, A., Willem, M., Berkowicz, T., andWekerle, H. (1999). Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat. Med. 5, 843-847.
13. Ford, M. L., and Evavold, B. D. (2005). Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35, 76-85.
14. Goverman, J. (1999). Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. Immunol. Rev. 169, 147-159.
15. Harrington, C. J., Paez, A., Hunkapiller, T., Mannikko, V., Brabb, T., Ahearn, M., Beeson, C., and Goverman, J. (1998). Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8, 571-580.
16. Hirst, C. L., Pace, A., Pickersgill, T. P., Jones, R., McLean, B. N., Zajicek, J. P., Scolding, N. J., and Robertson, N. P. (2008). Cam-path 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis. J. Neurol. 255, 231-238.
17. Holmes, S., Friese, M. A., Siebold, C., Jones, E. Y., Bell, J., and Fugger, L. (2005). Multiple sclerosis: MHC associations and therapeutic implications. Expert Rev. Mol. Med. 7, 1-17.
18. Hudrisier, D., Oldstone, M. B., and Gairin, J. E. (1997). The signal sequence of lymphocytic chori-omeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Virology 234, 62-73.
19. Huseby, E. S., and Goverman, J. (2000). Tolerating the nervous system: a delicate balance. J. Exp. Med. 191, 757-760.
20. Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Ohlen, C., and Goverman, J. (2001). A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194, 669-676.
21. Jilek, S., Schluep, M., Rossetti, A. O., Guignard, L., Le Goff, G., Pantaleo, G., and Du Pasquier, R. A. (2007). CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. Clin. Immunol. 123, 105-113.
22. Klavinskis, L. S., Whitton, J. L., Joly, E., and Oldstone, M. B. (1990). Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178, 393-400.
23. Klein, L., Klugmann, M., Nave, K. A., Tuohy, V. K., and Kyewski, B. (2000). Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6, 56-61.
24. Klenerman, P., Cerundolo, V., and Dun-bar, P. R. (2002). Tracking T cells with tetramers: new tales from new tools. Nat. Rev. Immunol. 2, 263-272.
25. (/(mice. Science 256, 1210-1213.
26. Krishnamoorthy, G., Saxena, A., Mars, L. T., Domingues, H. S., Mentele, R., Ben-Nun, A., Lassmann, H., Dorn-mair, K., Kurschus, F. C., Liblau, R. S., and Wekerle, H. (2009). Myelin-specific T cells also recognize neu-ronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat. Med. 15, 626-632.
27. Lee, Y. H., Ishida, Y., Rifa'i, M., Shi, Z., Isobe, K., and Suzuki, H. (2008). Essential role of CD8+ CD 122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J. Immunol. 180, 825-832.
28. Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D., and Wraith, D. C. (1995). Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3, 407-415.
29. Liu, G. Y., and Wraith, D. C. (1995). Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice - implications for autoimmunity. Int. Immunol. 7, 1255-1263.
30. Malmestrom, C., Lycke, J., Haghighi, S., Andersen, O., Carlsson, L., Waden-vik, H., and Olsson, B. (2008). Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. J. Neuroimmunol. 196, 159-165.
31. Manoury, B., Mazzeo, D., Fugger, L., Viner, N., Ponsford, M., Streeter, H., Mazza, G., Wraith, D. C., and Watts, C. (2002). Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3, 169-174.
32. Mars, L. T., Saikali, P., Liblau, R. S., and Arbour, N. (2011). Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim. Bio-phys.Acta 1812, 151-161.
33. Mathis, D., and Benoist, C. (2009). Aire. Annu. Rev. Immunol. 27, 287-312.
34. Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. (1995). Amyelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959.
35. Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. (1996). Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse Vb gene usage by T cells recognising the core epitope encephalitogenic for T cell receptor Vbeta-b and T cell receptor Vbeta-a H-2b mice. Eur. J. Immunol. 26, 2470-2479.
36. Montero, E., Nussbaum, G., Kaye, J. E, Perez, R., Lage, A., Ben-Nun, A., and Cohen, I. R. (2004). Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 23, 1-7.
37. Na, S. Y., Cao, Y., Toben, C., Nitschke, L., Stadelmann, C., Gold, R., Schimpl, A., and Hunig, T. (2008). Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 131, 2353-2365.
38. O'Connor, R. A., Malpass, K. H., and Anderton, S. M. (2007). The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J. Immunol. 179, 958-966.
39. O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C., and Anderton, S. M. (2008). Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181, 3750-3754.
40. Racadot, E., Rumbach, L., Bataillard, M., Galmiche, J., Henlin, J. L., Truttmann, M., Herve, P., and Wij-denes, J. (1993). Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients. J. Autoimmun. 6, 771-786.
41. Rumbach, L., Racadot, E., Armspach, J. P., Namer, I. J., Bonneville, J. F., Wij-denes, J., Marescaux, C., Herve, P., and Chambron, J. (1996). Biological assessment and MRI monitoring of the therapeutic efficacy of a monoclonal anti-T CD4 antibody in multiple sclerosis patients. Mult. Scler. 1, 207-212.
42. Saxena, A., Bauer, J., Scheikl, T., Zap-pulla, J., Audebert, M., Desbois, S., Waisman, A., Lassmann, H., Liblau, R. S., and Mars, L. T. (2008). Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 181, 1617-1621.
43. Seamons, A., Sutton, J., Bai, D., Baird, E., Bonn, N., Kafsack, B. F., Shabanowitz, J., Hunt, D. F., Beeson, C., and Goverman, J. (2003). Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J. Exp. Med. 197, 1391-1397.
44. Sonobe, Y., Jin, S., Wang, J., Kawanokuchi, J., Takeuchi, H., Mizuno, T., and Suzumura, A. (2007). Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J. Exp. Med. 213, 329-339.
45. Sun, D., Zhang, Y., Wei, B., Peiper, S. C., Shao, H., and Kaplan, H. J. (2003). Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules. Int. Immunol. 15, 261-268.
46. Sweenie, C. H., Mackenzie, K. J., Rone-Orugboh, A., Liu, M., and Anderton, S. M. (2007). Distinct T cell recognition of naturally processed and cryptic epitopes within the immunodominant 35-55 region of myelin oligodendrocyte glycoprotein.J. Neuroimmunol. 183, 7-16.
47. Tran, E. H., Hoekstra, K., van Rooi-jen, N., Dijkstra, C. D., and Owens, T. (1998). Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161, 3767-3775.
48. van Oosten, B. W., Lai, M., Hodgkin-son, S., Barkhof, F., Miller, D. H., Moseley, I. F., Thompson, A. J., Rudge, P., McDougall, A., McLeod, J. G., Adèr, H. J., and Polman, C. H. (1997). Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49, 351-357.
49. York, N. R., Mendoza, J. P., Ortega, S. B., Benagh, A., Tyler, A. F., Firan, M., and Karandikar, N. J. (2010). Immune regulatory CNS-reactive CD8(T cells in experimental autoimmune encephalomyelitis. J. Autoimmun. 35, 33-44.
50. Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R., and Steinman, L. (1985). T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355-358.